Walmart joins Arkansas initiative to transform care delivery

Luke Gale | | Health Exec | Policy & Regulations

Walmart has committed $670,000 to underwrite the Arkansas Payment Improvement Initiative, a statewide effort to transform healthcare delivery with the hopes of containing costs and improving quality.

By encouraging providers to engage in a variety of potentially cost-effective strategies, including patient engagement, care coordination and increased provision of preventive services, the Arkansas Payment Improvement Initiative is intended to increase the value of healthcare provided throughout the state, according to a statement. In addition to funding the public communications program and underwriting an annual statewide tracking report, Walmart also will serve on the initiative’s employer advisory council. 

Luke Gale

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
VA planning 83,000 layoffs as part of restructuring
HIMSS survey report: Beware insider threats to cybersecurity involving AI
HHS spokesperson abruptly resigns, reportedly after clash with RFK
Hospital faces $3.5M settlement after sharing patient data with Facebook
Philips pulls endovascular devices from market after safety issues prompt Class I recall

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.